Mainz Biomed MYNZ Partners with the Instituto de Microecologia to Expand ColoAlert Commercialization in Spain and Portugal

Mainz Biomed NV (NASDAQ: MYNZ) announced that it has added the Instituto de Microecologia in Madrid to its growing network of lab partners across Europe and in select international markets. ColoAlert®, Mainz Biomed’s flagship product, is a highly efficacious and easy-to-use, at-home detection test for colorectal cancer (CRC). For more…Read More